Compare, Analyse Wockhardt with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs MYLAN (US) - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   MYLAN
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
MYLAN
Dec-18
WOCKHARDT/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0123,493-   
Low Rs5321,923-   
Sales per share (Unadj.) Rs355.91,607.4-  
Earnings per share (Unadj.) Rs-60.343.6-  
Cash flow per share (Unadj.) Rs-46.8344.6-  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.81,739.0-  
Shares outstanding (eoy) m110.63514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.21.7 128.7%   
Avg P/E ratio x-12.862.0 -20.6%  
P/CF ratio (eoy) x-16.57.9 -210.0%  
Price / Book Value ratio x3.01.6 192.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,3791,393,313 6.1%   
No. of employees `0006.335.0 17.9%   
Total wages/salary Rs m9,3710-   
Avg. sales/employee Rs Th6,295.023,629.5 26.6%   
Avg. wages/employee Rs Th1,498.30-   
Avg. net profit/employee Rs Th-1,066.3641.6 -166.2%   
INCOME DATA
Net Sales Rs m39,369827,032 4.8%  
Other income Rs m1,2020-   
Total revenues Rs m40,571827,032 4.9%   
Gross profit Rs m18214,005 0.0%  
Depreciation Rs m1,495154,853 1.0%   
Interest Rs m2,55539,777 6.4%   
Profit before tax Rs m-2,83019,375 -14.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257-3,082 -8.3%   
Profit after tax Rs m-6,66922,457 -29.7%  
Gross profit margin %025.9 0.2%  
Effective tax rate %-9.1-15.9 57.1%   
Net profit margin %-16.92.7 -623.8%  
BALANCE SHEET DATA
Current assets Rs m33,796461,814 7.3%   
Current liabilities Rs m26,917336,713 8.0%   
Net working cap to sales %17.515.1 115.5%  
Current ratio x1.31.4 91.5%  
Inventory Days Days7984 94.9%  
Debtors Days Days8993 95.6%  
Net fixed assets Rs m39,664160,431 24.7%   
Share capital Rs m553440 125.6%   
"Free" reserves Rs m27,9680-   
Net worth Rs m28,522894,697 3.2%   
Long term debt Rs m21,731965,666 2.3%   
Total assets Rs m81,6202,399,926 3.4%  
Interest coverage x-0.11.5 -7.2%   
Debt to equity ratio x0.81.1 70.6%  
Sales to assets ratio x0.50.3 140.0%   
Return on assets %-5.02.6 -194.4%  
Return on equity %-23.42.5 -931.5%  
Return on capital %-7.73.2 -241.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,0190-   
CASH FLOW
From Operations Rs m684171,857 0.4%  
From Investments Rs m6,302-88,831 -7.1%  
From Financial Activity Rs m-7,695-80,061 9.6%  
Net Cashflow Rs m-6641,424 -46.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.39 Rs / USD

Compare WOCKHARDT With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare WOCKHARDT With: FULFORD INDIA  CADILA HEALTHCARE  WYETH  DIVIS LABORATORIES  J.B.CHEMICALS  



Today's Market

Sensex Ends 163 Points Higher; Metal and Realty Stocks Witness Buying(Closing)

It was indeed a volatile trading day for share markets in India today. After staging a gap-up opening, Indian share markets reversed gains.

Related Views On News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

WOCKHARDT SHARE PRICE


Oct 21, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT

WOCKHARDT - GLENMARK PHARMA COMPARISON

COMPARE WOCKHARDT WITH

FEATURED VIDEOS

Why ITC and not HUL is my Idea of a Good Investment Right Now

Contrarian Trading in PSU Banks

Why I Asked My Subscribers to Sell Stocks and Move into Cash?

How to Save Money by Exiting Stocks Before They Fall

More Featured Videos

MARKET STATS